OBJECTIVE: To find out whether B-type natriuretic peptide (BNP) detects silent myocardial ischaemia in patients with type 2 diabetes, since many of these patients have silent ischaemia leading to unexpected cardiac deaths. DESIGN: Prospective cross-sectional study with consecutive recruitment of patients. SETTING: Outpatient, single centre. PATIENTS: 219 patients with type 2 diabetes. Patients were excluded if they had a history or evidence of cardiac failure. OUTCOME MEASURES: BNP, echocardiography and exercise tolerance test (ETT). BNP was compared with the ETT result in all patients and specifically in those who had no apparent ischaemic heart disease (IHD). RESULTS: 121 patients had no history of IHD or cardiac failure and of these patients 85 had a clearly abnormal or normal ETT result. BNP was higher in patients with an abnormal than with a normal ETT (mean 58.2 (SD 46.3) v 24.4 (SD 15.7) pg/ml, p < 0.001). In univariate analysis BNP was an independent predictor of an abnormal ETT (p < 0.001). In multivariate analysis BNP remained an independent predictor of the ETT result. BNP concentration over 20 pg/ml predicted an abnormal ETT result with a sensitivity of 87% and specificity of 37%, and BNP over 40 pg/ml had a sensitivity of 63% and a specificity of 81%. CONCLUSION: BNP is of value in predicting silent ischaemia on exercise testing in asymptomatic patients with type 2 diabetes.
OBJECTIVE: To find out whether B-type natriuretic peptide (BNP) detects silent myocardial ischaemia in patients with type 2 diabetes, since many of these patients have silent ischaemia leading to unexpected cardiac deaths. DESIGN: Prospective cross-sectional study with consecutive recruitment of patients. SETTING:Outpatient, single centre. PATIENTS: 219 patients with type 2 diabetes. Patients were excluded if they had a history or evidence of cardiac failure. OUTCOME MEASURES: BNP, echocardiography and exercise tolerance test (ETT). BNP was compared with the ETT result in all patients and specifically in those who had no apparent ischaemic heart disease (IHD). RESULTS: 121 patients had no history of IHD or cardiac failure and of these patients 85 had a clearly abnormal or normal ETT result. BNP was higher in patients with an abnormal than with a normal ETT (mean 58.2 (SD 46.3) v 24.4 (SD 15.7) pg/ml, p < 0.001). In univariate analysis BNP was an independent predictor of an abnormal ETT (p < 0.001). In multivariate analysis BNP remained an independent predictor of the ETT result. BNP concentration over 20 pg/ml predicted an abnormal ETT result with a sensitivity of 87% and specificity of 37%, and BNP over 40 pg/ml had a sensitivity of 63% and a specificity of 81%. CONCLUSION:BNP is of value in predicting silent ischaemia on exercise testing in asymptomatic patients with type 2 diabetes.
Authors: B Stanek; B Frey; M Hülsmann; R Berger; B Sturm; J Strametz-Juranek; J Bergler-Klein; P Moser; A Bojic; E Hartter; R Pacher Journal: J Am Coll Cardiol Date: 2001-08 Impact factor: 24.094
Authors: J A de Lemos; D A Morrow; J H Bentley; T Omland; M S Sabatine; C H McCabe; C Hall; C P Cannon; E Braunwald Journal: N Engl J Med Date: 2001-10-04 Impact factor: 91.245
Authors: J J de Vreede-Swagemakers; A P Gorgels; W I Dubois-Arbouw; J W van Ree; M J Daemen; L G Houben; H J Wellens Journal: J Am Coll Cardiol Date: 1997-11-15 Impact factor: 24.094
Authors: S Bacci; M Villella; A Villella; T Langialonga; M Grilli; A Rauseo; S Mastroianno; S De Cosmo; R Fanelli; V Trischitta Journal: Eur J Endocrinol Date: 2002-11 Impact factor: 6.664
Authors: L J Shaw; E D Peterson; L K Shaw; K L Kesler; E R DeLong; F E Harrell; L H Muhlbaier; D B Mark Journal: Circulation Date: 1998-10-20 Impact factor: 29.690
Authors: Wendy Ying; Di Zhao; Pamela Ouyang; Vinita Subramanya; Dhananjay Vaidya; Chiadi E Ndumele; Kavita Sharma; Sanjiv J Shah; Susan R Heckbert; Joao A Lima; Christopher R deFilippi; Matthew J Budoff; Wendy S Post; Erin D Michos Journal: J Clin Endocrinol Metab Date: 2018-11-01 Impact factor: 5.958
Authors: Juliano Lara Fernandes; Carlos Vicente Serrano; Flavia Toledo; Maria Fernanda Hunziker; Augusto Zamperini; Fabio H Teo; Romulo T Oliveira; Maria Heloisa Blotta; Maria Urbana Rondon; Carlos Eduardo Negrão Journal: Clin Res Cardiol Date: 2010-09-12 Impact factor: 5.460
Authors: Magda Cepkova; Vineet Kapur; Xiushui Ren; Thomas Quinn; Hanjing Zhuo; Elyse Foster; Michael A Matthay; Kathleen D Liu Journal: Ann Intensive Care Date: 2011-06-13 Impact factor: 6.925
Authors: Hari K Parthasarathy; Burkert Pieske; Marianne Weisskopf; Chris D Andrews; Patrick Brunel; Allan D Struthers; Thomas M MacDonald Journal: Eur J Heart Fail Date: 2009-10 Impact factor: 15.534
Authors: Paul Welsh; Orla Doolin; Peter Willeit; Chris Packard; Peter Macfarlane; Stuart Cobbe; Vilmundur Gudnason; Emanuele Di Angelantonio; Ian Ford; Naveed Sattar Journal: Eur Heart J Date: 2012-08-31 Impact factor: 29.983